[go: up one dir, main page]

WO2025019711A3 - Predicting therapeutic response based on biomarker signatures - Google Patents

Predicting therapeutic response based on biomarker signatures Download PDF

Info

Publication number
WO2025019711A3
WO2025019711A3 PCT/US2024/038611 US2024038611W WO2025019711A3 WO 2025019711 A3 WO2025019711 A3 WO 2025019711A3 US 2024038611 W US2024038611 W US 2024038611W WO 2025019711 A3 WO2025019711 A3 WO 2025019711A3
Authority
WO
WIPO (PCT)
Prior art keywords
therapeutic response
response based
predicting therapeutic
biomarker signatures
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/US2024/038611
Other languages
French (fr)
Other versions
WO2025019711A2 (en
Inventor
Michael Howell
Emad SAMANI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dermtech LLC
Original Assignee
Dermtech LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermtech LLC filed Critical Dermtech LLC
Publication of WO2025019711A2 publication Critical patent/WO2025019711A2/en
Publication of WO2025019711A3 publication Critical patent/WO2025019711A3/en
Priority to US19/304,519 priority Critical patent/US20250372262A1/en
Anticipated expiration legal-status Critical
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Disclosed herein are systems and methods of generating skin disease treatment classes. Also described herein are methods for using the methods described herein for assessing potential response to therapies for treating skin diseases or skin conditions.
PCT/US2024/038611 2014-02-04 2024-07-18 Predicting therapeutic response based on biomarker signatures Pending WO2025019711A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US19/304,519 US20250372262A1 (en) 2014-02-04 2025-08-19 Methods and systems for detecting skin conditions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363527670P 2023-07-19 2023-07-19
US63/527,670 2023-07-19

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US19/304,519 Continuation-In-Part US20250372262A1 (en) 2014-02-04 2025-08-19 Methods and systems for detecting skin conditions

Publications (2)

Publication Number Publication Date
WO2025019711A2 WO2025019711A2 (en) 2025-01-23
WO2025019711A3 true WO2025019711A3 (en) 2025-04-17

Family

ID=94282673

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2024/038611 Pending WO2025019711A2 (en) 2014-02-04 2024-07-18 Predicting therapeutic response based on biomarker signatures

Country Status (1)

Country Link
WO (1) WO2025019711A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022098756A1 (en) * 2020-11-03 2022-05-12 WUGEN, Inc. Chimeric antigen receptor cell therapy
US20220160729A1 (en) * 2017-04-01 2022-05-26 Avm Biotechnology, Llc Replacement of Cytotoxic Preconditioning Before Cellular Immunotherapy
WO2022187196A1 (en) * 2021-03-02 2022-09-09 Dermtech, Inc. Predicting therapeutic response

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220160729A1 (en) * 2017-04-01 2022-05-26 Avm Biotechnology, Llc Replacement of Cytotoxic Preconditioning Before Cellular Immunotherapy
WO2022098756A1 (en) * 2020-11-03 2022-05-12 WUGEN, Inc. Chimeric antigen receptor cell therapy
WO2022187196A1 (en) * 2021-03-02 2022-09-09 Dermtech, Inc. Predicting therapeutic response

Also Published As

Publication number Publication date
WO2025019711A2 (en) 2025-01-23

Similar Documents

Publication Publication Date Title
BR112018068906A2 (en) composition, method, risk reduction method, prevention or treatment of an individual having an autoimmune disease or disorder, method of inducing degradation of a target protein in a cell, method for reducing risk, preventing or treating a disease state or disorder in a patient wherein the unregulated protein activity is responsible for said disease or condition, method for reducing the risk, preventing or treating cancer in an individual, and method of treating a genetic disease or disorder in an individual
Wu et al. Acute traumatic coma awakening by right median nerve electrical stimulation: a randomised controlled trial
Kim et al. Neuroepigenetics of post-traumatic stress disorder
Mascarenhas et al. Interim analysis of the myeloproliferative disorders research consortium (MPD-RC) 112 global phase III trial of front line pegylated interferon alpha-2a vs. hydroxyurea in high risk polycythemia vera and essential thrombocythemia
De Tommaso et al. Suggestion and pain in migraine: a study by laser evoked potentials
Tankus et al. Impaired timing of speech-related neurons in the subthalamic nucleus of Parkinson disease patients suffering speech disorders
Anzak et al. Subcortical evoked activity and motor enhancement in Parkinson's disease
WO2025019711A3 (en) Predicting therapeutic response based on biomarker signatures
Svensson et al. Modulation of an inhibitory reflex in single motor units in human masseter by tonic painful stimulation
Astikainen et al. Somatosensory event-related potentials in the rabbit cerebral and cerebellar cortices: a correspondence with mismatch responses in humans
Portnova et al. EEG of patients in coma after traumatic brain injury reflects physical parameters of auditory stimulation but not its emotional content
Cacace et al. Blast overpressures as a military and occupational health concern
Wang et al. Excitability changes induced in the human auditory cortex by transcranial alternating current stimulation
Gaylis et al. Neuroimmune modulation for drug-refractory rheumatoid arthritis: long-term safety and efficacy in patients enrolled in a pilot vagus nerve stimulation study
Baciu et al. Effect of visual feedback on speech recovery and language plasticity in patients with post-stroke non-fluent aphasia. Functional MRI assessment
Rayner et al. Reduced attention-driven auditory sensitivity inhallucination-prone individuals
Ilg et al. Motor rehabilitation of cerebellar disorders
Kaewpijit et al. Baseline resting EEG measures differentiate rTMS treatment responders and non-responders
Gonzalez et al. Where Do You Sleep?–Actigraphic Sleep Quality Mediates the Relationship between Neighborhood Disadvantage and Physical Function in Individuals with Painful Knee Osteoarthritis
Miyazaki et al. POS0546 SAFETY AND EFFICACY OF ANIFROLUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) WITH MINOR FLARES AFTER ACHIEVING THE LUPUS LOW DISEASE ACTIVITY STATE (LLDAS) IN REAL-WORLD CLINICAL PRACTICE: LOOPS REGISTRY
Zaytsev et al. Possible strategies for the implementation of WHO program on the elimination of hepatitis C in Ukraine by 2030
Luo et al. An innovative predictive model for assessing tinnitus sound therapy outcomes: integrating audiological and psychometric variables
Carrión-Barberà et al. ABS1107 COMPLETE BLOOD COUNT AND THEIR RATIOS CAN SUPPORT DIAGNOSIS AND SURVIVAL OUTCOMES IN GIANT CELL ARTERITIS
Nackers et al. Food insecurity is associated with lower rates of bariatric surgery and longer timeframe to completing surgery
Sagard et al. ABS0372 DO AXIAL SPONDYLOARTHRITIS PATIENTS WITH PERIPHERAL INVOLVEMENT HAVE MORE SEVERE DISEASE INSIGHTS FROM THE SPARTAKUS COHORT

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24843984

Country of ref document: EP

Kind code of ref document: A2